Mani, H., Nester, N., Rauscher, G., Johnson, T., Hafeez, Z., Lal, D., Presley, C., Kincaid, H., McIntosh, A., Blackham, A., Nair, S. (2025). Retrospective study of unresectable stage III or stage IV melanoma refractory to immune checkpoint and BRAF/MEK inhibitors, treated with triplet vs doublet therapy: A single institution experience.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e21500